Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision MedicineChantal Pauli, Mark A. Rubin, Benjamin D. Hopkins et al.|Cancer Discovery|2017Cited by 964
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Himisha Beltran, Reid Shaw et al.|Nature Communications|2018Cited by 364
Supplementary Table 5 from Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision MedicineChantal Pauli, Mark A. Rubin, Benjamin D. Hopkins et al.|Unknown|2023Cited by 0
Supplementary Table 3 from Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision MedicineChantal Pauli, Mark A. Rubin, Benjamin D. Hopkins et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision MedicineChantal Pauli, Mark A. Rubin, Benjamin D. Hopkins et al.|Unknown|2023Cited by 0